
Clarity Pharmaceuticals: A New Dawn in Cancer Treatment?
Clarity Pharmaceuticals Ltd unveils a promising cancer therapy focused on the fibroblast activation protein (FAP)-targeted radiopharmaceutical. The innovative approach targets tumor stroma, crucial for cancer growth, reducing harmful side effects compared to conventional treatments. SAR-bisFAP, a key compound, enhances treatment precision using